Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Return on Assets (2016 - 2021)

Syndax Pharmaceuticals (SNDX) has disclosed Return on Assets for 6 consecutive years, with 0.08% as the latest value for Q3 2021.

  • For Q3 2021, Return on Assets rose 27.0% year-over-year to 0.08%; the TTM value through Sep 2021 reached 0.08%, up 27.0%, while the annual FY2025 figure was 0.4%, 7.0% up from the prior year.
  • Return on Assets hit 0.08% in Q3 2021 for Syndax Pharmaceuticals, up from 0.15% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.08% in Q3 2021 and bottomed at 0.84% in Q4 2018.
  • Average Return on Assets over 5 years is 0.51%, with a median of 0.46% recorded in 2017.
  • Year-over-year, Return on Assets crashed -38bps in 2018 and then soared 52bps in 2020.
  • Syndax Pharmaceuticals' Return on Assets stood at 0.46% in 2017, then plummeted by -82bps to 0.84% in 2018, then increased by 2bps to 0.82% in 2019, then surged by 64bps to 0.3% in 2020, then soared by 73bps to 0.08% in 2021.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.08%, 0.15%, and 0.19% for Q3 2021, Q2 2021, and Q1 2021 respectively.